A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/05/2009	US20090274689 For improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size in absence of removal of the arterial obstruction
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274687 Attenuation of hypoxia induced cardiovascular disorders
11/05/2009	US20090274686 Nucleoside phosphonate derivatives
11/05/2009	US20090274685 Ilt3 polypeptides and uses thereof
11/05/2009	US20090274684 Methods for the Identification of Modulators of OSGPR114 or OSGPR78 Activity, and their use in the Treatment of Disease
11/05/2009	US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009	US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009	US20090274647 Immunotherapeutic Formulations with Interleukin-2-Neutralizing Capacity
11/05/2009	US20090274626 TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
11/05/2009	US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009	US20090274619 Tumor vasculature markers and methods of use therof
11/05/2009	US20090274618 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/05/2009	CA2726007A1 Vaccine compositions and methods
11/05/2009	CA2723197A1 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
11/05/2009	CA2723143A1 Methods and compositions for prostate cancer immunotherapy
11/05/2009	CA2722765A1 Nanoparticles for use in pharmaceutical compositions
11/05/2009	CA2722664A1 Compositions for treating an inflammatory autoimmune condition
11/05/2009	CA2722137A1 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	CA2722109A1 Potent conjugates and hydrophilic linkers
11/05/2009	CA2721614A1 Cytotoxic immunoglobulin
11/05/2009	CA2720647A1 Levels of april in serum and use in diagnostic methods
11/05/2009	CA2717987A1 Inhibitors of gm-csf and il-17 for therapy
11/04/2009	EP2113516A1 Antibodies against C5 inhibiting type II endothelial cell activation
11/04/2009	EP2113511A1 Dna vaccines for fish
11/04/2009	EP2113255A1 Cytotoxic immunoglobulin
11/04/2009	EP2113254A1 Compositions for treating an inflammatory auto-immune condition
11/04/2009	EP2112996A1 Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen
11/04/2009	EP2112930A2 Modulation of nkt cell activity with antigen-loaded cdid molecules
11/04/2009	EP1682180B1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
11/04/2009	EP1668114B1 Polypeptide display libraries and methods of making and using thereof
11/04/2009	EP1559721B1 Fprl1 ligands and use thereof
11/04/2009	EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009	EP1098910B1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
11/04/2009	EP1032660B1 Method of identifying binding site domains that retain the capacity of binding to an epitop
11/04/2009	EP1004299B1 Vaccine precursors, vaccines for treating tumors
11/04/2009	CN101573137A Methods of vaccine administration
11/04/2009	CN101573108A Particles of paclitaxel and albumin in combination with bevacizumab against cancer
11/03/2009	US7612192 Neisseria genomic sequences and methods of their use
11/03/2009	US7612183 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders
11/03/2009	US7612182 Anti-IL-6 antibodies, compositions, methods and uses
11/03/2009	US7612181 Dual variable domain immunoglobulin and uses thereof
11/03/2009	US7612179 Alzheimer's disease, systemic amyloidosis and other amyloid disorders; kits
11/03/2009	US7612175 Having an SR structure and a collectin-like structure ; drug screening; , diabetic complications and Alzheimer's disease, hyper beta -lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypo alpha -lipoproteinemia, transplantation, atherectomy, post angiogenic restenosis, bacterial infections
11/03/2009	US7612174 Scavenger receptor
11/03/2009	US7612172 Immunization; used to elicit a humoral or cellular immune response
11/03/2009	US7612168 Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV
11/03/2009	US7612044 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/03/2009	US7612038 Stabilizing dystrophin associated protein complexes; abnormal synapses or neuromuscular junction disorders
11/03/2009	US7612019 Bioassay; membrane proteins; fusion proteins; capable of binding c-reactive protein; flow cytometry
11/03/2009	US7611904 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
11/03/2009	US7611884 Toxoplasma gondii nucleic acid molecules
11/03/2009	US7611879 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders
11/03/2009	US7611721 Adjuvant combination formulations
11/03/2009	US7611720 Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
11/03/2009	US7611719 Enterovirus, vaccines, medicaments and diagnostic kits
11/03/2009	US7611718 Attenuation of cytomegalovirus virulence
11/03/2009	US7611717 Using ORF 5 polypeptide of a VR2332 virus as evaluative tool in diagnosisng porcine reproductive and respiratory syndrome (PRRS) virus infection
11/03/2009	US7611714 Chimeric immunogen comprising a receptor binding domain, a translocation domain, and a Pseudomonas pilin peptide; elicit humoral, cell-mediated and secretory immune responses against the heterologous antigen
11/03/2009	US7611713 Inducing cellular immune responses to hepatitis B virus using peptide compositions
11/03/2009	US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009	US7611711 VEGFR-3 inhibitor materials and methods
11/03/2009	US7611709 Contains one antibody and lactosucrose, glucosyl sucrose or maltosyl sucrose; powders made through spray drying or freeze drying
11/03/2009	US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009	US7611707 Glycoprotein VI antibodies and methods thereof
11/03/2009	US7611706 RG1 antibodies and uses thereof
11/03/2009	US7611705 Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases
11/03/2009	US7611704 Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
11/03/2009	US7611703 Urogenital disorders; determining the level of one or more KCAT peptide; Lysosomal associated membrane protein 1 (LAMP1)
11/03/2009	US7611702 TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/03/2009	CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009	CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009	CA2205379C Yeast-based delivery vehicles
11/03/2009	CA2188293C Herpesviruses transformed to express gd in vitro
11/03/2009	CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
11/03/2009	CA2105618C Humanized antibodies to ganglioside gm2
10/2009
10/30/2009	CA2699190A1 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
10/29/2009	WO2009132283A2 Method for treating autoimmune disorders
10/29/2009	WO2009132251A2 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies
10/29/2009	WO2009132209A2 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/29/2009	WO2009132195A1 Immortal avian cell line and methods of use
10/29/2009	WO2009132130A2 Methods of identifying anti-inflammatory compounds
10/29/2009	WO2009132082A2 Immunogenic compositions containing ceramide and methods of use thereof
10/29/2009	WO2009132050A2 Auris formulations for treating otic diseases and conditions
10/29/2009	WO2009131995A1 Nanoemulsion influenza vaccine
10/29/2009	WO2009131752A2 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
10/29/2009	WO2009131730A2 IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS
10/29/2009	WO2009131712A2 Regulatory b cells and their uses
10/29/2009	WO2009131681A2 Hcv e2 construct compositions and methods
10/29/2009	WO2009131673A1 Targeted treatment for subjects with estrogen receptor negative and progesterone receptor negative breast cancers
10/29/2009	WO2009131643A1 Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
10/29/2009	WO2009131606A2 Viral inactivation using crosslinkers and detergents
10/29/2009	WO2009131605A2 Fusion partner cell line for preparation of hybrid cells expressing human antibodies
10/29/2009	WO2009131553A2 Methods of altering bone growth by administration of sost or wise antagonist or agonist
10/29/2009	WO2009131487A1 Method for producing operational standards of serums containing hepatitis c virus antibodies
10/29/2009	WO2009131453A1 Compositions and methods to enhance the immune system.
10/29/2009	WO2009131256A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009	WO2009130618A2 Flagellin polypeptide vaccines
10/29/2009	WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009	WO2009130508A1 Adjuvants for use in vaccination

1 ... 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 ... 1823